Skip to main content
. 2013 Sep 18;9:1411–1415. doi: 10.2147/NDT.S50135

Figure 2.

Figure 2

Comparison between high- and low-frequency subgroups for symptoms of gastroesophageal reflux disease (FSSG) scores (±standard error) in the rivastigmine patch (18 mg) with domperidone (30 mg) (RWD) and rivastigmine patch (18 mg) without domperidone (RWOD) groups.

Note: #P < 0.05 versus baseline.